These studies are an important first step toward investigating L205R‐PKACα as a therapeutic molecular target for the treatment of ACTH‐independent Cushing's syndrome. The gene discussed is PRKACA; the disease is Cushing syndrome due to macronodular adrenal hyperplasia.